title: Ibandronate in the Treatment of Pediatric Osteoporosis.
abstract: We administered oral ibandronate (once a month) to 7 children (6 boys) with low bone mineral density and prevalent low energy fractures. We observed a significant increase (17%) in bone density after one year and additional 3% increase after second year. No further fractures occurred.
authors: Departments of #*Pediatrics, Pardubice Hospital, Pardubice; *Klatovy Hospital, Klatovy; and $Department of Pediatrics, I Medical Facility, Charles University, Prague; Czech Republic. *kutilek@nemkt.cz.
authors: Stepan
authors: S
authors: Kutilek
authors: Ivana
authors: I
authors: Plasilova
authors: Jan
authors: J
authors: Langer
mesh_terms: D000293:Adolescent; D015519:Bone Density; D002648:Child; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D000077557:Ibandronic Acid; D008297:Male; D010024:Osteoporosis / Q000188:drug therapy*
chemical_list: D004164:Diphosphonates; D000077557:Ibandronic Acid